EFPIA - NEWSLETTER

EFPIA Newsletter 26 January 2017

26 January 2017

News

23 January 2017 170123 European Commission Initiative Improves Information for Patients on Biosimilar Medicines...

From our blog

25 January 2017 25012017 Ageing Nation’s Heritage to Benefit Registry-Based Research (Guest blog)

An ageing population translates into increasing future healthcare expenses

Events calendar

28 MAR 2017

DIA BioVenture Day Glasgow, UK

Is the current Bioventure paradigm delivering return for patients and investors?" is the key question to be addressed...

Learn more →

29 MAR 2017

DIA EuroMeeting 2017 Glasgow, UK

DIA is the global forum for knowledge exchange that fosters innovation to raise the level of health and well-being worldwide...

Learn more →

What we are reading

It’s time to reduce, replace and re-think the use of antimicrobials in animals 26 January 2017 (EMA)

HARMONY: Better care of patients with haematologic malignancies kicked off! 26 January 2017 (HARMONY)

‘There will be lots of benefits to patients’ – an interview with the SAFE-T project coordinators... 26 January 2017 (IMI)

PROactive draws to a close, delivers on its promises – an interview with project coordinators... 26 January 2017 (IMI)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶